Zhang Gao-Jia, Zhang Shao-Ke, Wang Zan, Zhu Yi-Xin, Kong Jun, Huang Li-Li, Guo Yi-Jing, Wang Yan-Juan, Zou Rong-Cheng, Xie Chun-Ming
Department of Neurology, Nanjing Lishui People's Hospital, Nanjing, China.
School of Medicine, Southeast University, Nanjing, China.
Front Neurol. 2020 Apr 21;11:295. doi: 10.3389/fneur.2020.00295. eCollection 2020.
Isolated cerebral mucormycosis is a clinical type of mucormycosis that is estimated to account for 8% of all mucormycosis cases. The clinical symptoms of isolated cerebral mucormycosis are elusive, and thus conventional techniques often lake sensitivity and specificity. Moreover, cultures are often negative, even when direct microscopy examination is positive. Although histopathology will probably remain the gold standard for the diagnosis of mucormycosis, obtaining a biopsy specimen is not always feasible in most vulnerable populations. Thus, molecular approaches are currently used as an advantageous assistant examination method to improve the early identification of the causative agent and subsequently guide therapy to improve the prognosis of patients. Here, we report a case of isolated cerebral mucormycosis caused by in a healthy young adult that was identified using next-generation sequencing technology.
孤立性脑毛霉菌病是毛霉菌病的一种临床类型,估计占所有毛霉菌病病例的8%。孤立性脑毛霉菌病的临床症状难以捉摸,因此传统技术往往缺乏敏感性和特异性。此外,即使直接显微镜检查呈阳性,培养结果也常常为阴性。尽管组织病理学可能仍是毛霉菌病诊断的金标准,但在大多数脆弱人群中获取活检标本并不总是可行的。因此,分子方法目前被用作一种有利的辅助检查方法,以改善病原体的早期识别,进而指导治疗以改善患者的预后。在此,我们报告一例由 引起的健康年轻成人孤立性脑毛霉菌病病例,该病例是使用下一代测序技术确诊的。 (注:原文中“caused by ”后面缺失具体内容)